HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease.

AbstractBACKGROUND AND PURPOSE:
Controversies concerning the significance of lipid abnormalities in stroke come mostly from the researches that studied lipid profile without considering stroke aetiologies. We investigated the prevalence of LDL phenotype B and other lipid abnormalities in stroke survivors with large vessel disease (LVD) or small vessel disease (SVD) (TOAST criteria) and in control subjects (CS).
METHODS:
We studied 30 patients with LVD and 41 patients with SVD screened out of 585 stroke patients and 30 CS who fulfilled the following exclusion criteria: cardiac disorders, renal or hepatic failure, diabetes mellitus, or treatment with lipid-lowering agents. At least 3 months after stroke, the concentrations of total cholesterol (TC), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglycerides (TGs), apolipoprotein E (apoE), and lipoprotein (a) [lp(a)] were measured and LDL phenotypes and apoE isoforms were identified.
RESULTS:
Patients with LVD had significantly higher concentrations of LDL-C than CS (p<0.05). They had higher concentrations of TGs and lower concentrations of HDL-C than patients with SVD and CS (p<0.05). LDL phenotype B was more frequent in patients with LVD (63.3%) than in patients with SVD (39.0%) or in CS (16.7%) (p<0.05). The concentration of apoE was higher in patients with LVD than in patients with SVD or in CS (p<0.05). The percentage of patients with increased level of lp(a) (i.e., >30 mg/ml) was greater in patients with LVD (36.7%) than in CS (10%) (p<0.05).
CONCLUSIONS:
Patients with stroke due to LVD, but not SVD, have high prevalence of atherogenic lipid abnormalities, including increased frequency of LDL phenotype B and higher percentage of increased lp(a) level, like patients with other atherogenic diseases.
AuthorsAgnieszka Slowik, Tomasz Iskra, Wojciech Turaj, Jadwiga Hartwich, Aldona Dembinska-Kiec, Andrzej Szczudlik
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 214 Issue 1-2 Pg. 11-6 (Oct 15 2003) ISSN: 0022-510X [Print] Netherlands
PMID12972382 (Publication Type: Journal Article)
Chemical References
  • Apolipoproteins E
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Lipoprotein(a)
  • Triglycerides
  • Cholesterol
Topics
  • Aged
  • Apolipoproteins E (blood)
  • Brain Ischemia (blood, epidemiology, genetics)
  • Cerebral Arteries (pathology, physiopathology)
  • Cholesterol (blood)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood, genetics)
  • Female
  • Humans
  • Hyperlipidemias (blood, epidemiology, genetics)
  • Intracranial Arteriosclerosis (blood, epidemiology, genetics)
  • Lipoprotein(a) (blood)
  • Male
  • Middle Aged
  • Phenotype
  • Prevalence
  • Risk Factors
  • Stroke (blood, epidemiology, genetics)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: